Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
45.81
-0.37 (-0.80%)
At close: Jun 5, 2026, 4:00 PM EDT
46.72
+0.91 (1.99%)
After-hours: Jun 5, 2026, 7:53 PM EDT

Travere Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,2603,4741,5236781,3521,940
Market Cap Growth
188.97%128.05%124.84%-49.89%-30.30%36.22%
Enterprise Value
4,3233,4741,480510.571,3051,645
Last Close Price
45.8138.2117.428.9921.0331.04
Forward PE
18.9138.08----
PS Ratio
7.947.086.534.6712.3514.71
PB Ratio
42.8830.2625.793.3731.556.42
P/TBV Ratio
43.3529.6923.263.3331.296.15
P/FCF Ratio
107.5491.95----
P/OCF Ratio
107.5491.95----
EV/Sales Ratio
8.067.086.353.5211.9212.48
EV/FCF Ratio
109.1391.95----
Debt / Equity Ratio
3.262.815.541.999.410.85
Debt / EBITDA Ratio
20.36-----
Debt / FCF Ratio
8.308.70----
Net Debt / Equity Ratio
0.640.050.52-0.81-1.00-0.96
Net Debt / EBITDA Ratio
3.91-2.85-0.110.460.141.56
Net Debt / FCF Ratio
1.600.16-0.130.580.2314.62
Asset Turnover
0.920.820.340.200.150.19
Inventory Turnover
0.250.310.230.640.750.51
Quick Ratio
2.812.521.983.313.284.58
Current Ratio
3.132.742.083.473.424.70
Return on Equity (ROE)
-34.75%-57.80%-246.75%-308.90%-192.18%-84.66%
Return on Assets (ROA)
-10.02%-10.69%-46.85%-53.15%-44.18%-28.87%
Return on Invested Capital (ROIC)
-33.22%-28.78%-141.47%-191.95%-144.57%-89.13%
Return on Capital Employed (ROCE)
-13.04%-14.98%-64.48%-68.01%-54.07%-34.17%
FCF Yield
0.93%1.09%----
Buyback Yield / Dilution
-10.28%-13.09%-6.22%-16.48%-6.56%-25.86%
Total Shareholder Return
-10.28%-13.09%-6.22%-16.48%-6.56%-25.86%
SEC Filings: 10-K · 10-Q